Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Mar 26, 2012	YANCOPOULOS GEORGE Director, EVP CSO President Regeneron Re	Director, EVP CSO President Regeneron Re	Form 4	Open market or private sale of non-derivative or derivative security	32,140	$120.21	867,216
Dec 16, 2008	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	32,946	$16.42	603,157
Sep 17, 2003	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	34,250	--	--
Sep 17, 2003	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	34,250	$4.25	92,836
Apr 29, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO	Director, Bd. Co-Chair, President & CSO	Form 4	Bona fide gift	36,296	--	--
May 07, 2013	YANCOPOULOS GEORGE Director, President Regeneron Laboratori	Director, President Regeneron Laboratori	Form 4	Open market or private sale of non-derivative or derivative security	38,267	$263.22	1,106,795
Dec 14, 2012	YANCOPOULOS GEORGE Director, EVP CSO Pres Regen Res Labs	Director, EVP CSO Pres Regen Res Labs	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	38,391	$179.13	1,294,650
Dec 14, 2011	YANCOPOULOS GEORGE Director, EVP CSO President Regeneron Re	Director, EVP CSO President Regeneron Re	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	38,516	$51.18	860,754
Apr 13, 2007	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	38,835	$24.60	118,705
Dec 16, 2013	YANCOPOULOS GEORGE Director, Pres Regeneron Labs	Director, Pres Regeneron Labs	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	42,974	$272.73	1,063,638

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media